Executive Summary
The digest covers $3.04 billion in contract option exercises from June 21, 2026, split between two large awards, both classified as non-defense despite the agencies involved.
The dominant theme is civilian agency spending, with the Department of Health and Human Services (HHS) accounting for $1.78 billion to Leidos Biomedical Research Inc. and the Department of Homeland Security (DHS) awarding $1.26 billion to Bollinger Shipyards Lockport, L.L.C. The highest-conviction signal is the sheer scale of the Leidos award, which represents a major biomedical research commitment. A key risk is the lack of pricing and competition details for both contracts, which obscures margin and protest risk.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Contract Option Exercises digest from June 20, 2026.
Investment Signals (2)
- Leidos Biomedical Research Inc. wins $1.78B HHS contract option exercise (HIGH)▲
Leidos Biomedical Research Inc. received a $1.78 billion contract option exercise from HHS, signaling sustained demand for biomedical research services and a strong incumbent position.
- Bollinger Shipyards Lockport secures $1.26B DHS contract option exercise (HIGH)▲
Bollinger Shipyards Lockport, L.L.C. was awarded a $1.26 billion contract option exercise from DHS, indicating continued investment in maritime assets for homeland security and a stable revenue stream for the shipbuilder.
Risk Flags (2)
- Execution [MEDIUM RISK]▼
Both contracts lack pricing details (fixed-price vs. cost-plus) and competition signals, raising execution risk for Leidos Biomedical Research Inc. and Bollinger Shipyards Lockport, L.L.C. if margins are squeezed or if protests emerge.
- Concentration [MEDIUM RISK]▼
The digest shows heavy concentration in two civilian agencies (HHS and DHS) with no defense-related awards, exposing investors to civilian budget volatility and potential Continuing Resolution (CR) impacts on non-defense spending.
Opportunities (2)
- ◆
Leidos Biomedical Research Inc.'s $1.78B award suggests a long-term biomedical research pipeline, potentially expanding into pandemic preparedness or biodefense, which could drive further contract growth.
- ◆
Bollinger Shipyards Lockport's $1.26B DHS award could position the company for future Coast Guard or Navy shipbuilding programs, given the overlap in maritime requirements.
Sector Themes (2)
- ◆
Despite the absence of defense contracts, HHS and DHS awarded $3.04 billion in option exercises, demonstrating that civilian agencies remain a significant source of large contract awards, particularly in biomedical research and maritime security.
- ◆
The $1.26 billion DHS award to Bollinger Shipyards Lockport underscores ongoing investment in maritime assets for homeland security, a theme that may extend to broader naval shipbuilding.
Watch List (2)
- 👁
{"entity"=>"Leidos Holdings Inc.", "reason"=>"The $1.78B HHS award is a major revenue contributor; any protest or budget cut could impact earnings.", "trigger"=>"GAO protest filing deadline (10 days post-award), FY2027 HHS budget release"}
- 👁
{"entity"=>"Bollinger Shipyards", "reason"=>"The $1.26B DHS award signals strong demand for maritime assets; watch for follow-on Coast Guard contracts.", "trigger"=>"DHS FY2027 budget request, Coast Guard Polar Security Cutter program updates"}
Get daily alerts with 2 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 2 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Contract Option Exercises
🇺🇸 More from United States
View all →June 21, 2026
General Federal Contracts — June 21, 2026
General Federal Contracts
June 21, 2026
High-Value Federal Grants ($5M+) — June 21, 2026
High-Value Federal Grants ($5M+)
June 21, 2026
Mega Contracts Monitor ($100M+) — June 21, 2026
Mega Contracts Monitor ($100M+)
June 21, 2026
All HHS Contracts — June 21, 2026
All HHS Contracts